More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products|Roots Analysis
There is a growing body of evidence supportingthe vast applicability and superiority of treatment outcomes of stem celltherapies, compared to conventional treatment options. In fact, the unmet needswithin this domain have spurred the establishment of many start-ups in recentyears. Further, recent studies suggest that mesenchymal stem cells mesenchymalstem cells can be effectively used to improve patients' resistance to theSARS-CoV-2 virus induced pneumonia leading to speedy recovery.
To order this 500+ page report, which features 185+figures and 220+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html
The USD 8.5 billion (by 2030) financial opportunitywithin the stem cell therapies market has been analyzed across the followingsegments:
§ Source of stem cell
§ Allogeneic
§ Autologous
§ Origin of stem cell
§ Adult
§ Embryonic
§ Type of stem cell
§ Hematopoietic
§ Mesenchymal
§ Progenitor
§ Others
§ Lineage of stem cell
§ Adipose Tissue
§ Bone Marrow
§ Cord Blood
§ Others
§ Route ofAdministration
§ Intraarticular
§ Intracoronary
§ Intramuscular
§ Intramyocardial
§ Intrathecal
§ Intravenous
§ SurgicalImplantations
§ Others
§ Therapeutic Area
§ Autoimmune /Inflammatory Disorder
§ CardiovascularDisorders
§ Metabolic Disorder
§ MusculoskeletalDisorders
§ Oncological Disorders
§ NeurologicalDisorders
§ Ophthalmic Disorders
§ Others
§ End Users
§ Ambulatory SurgeryCenters
§ Hospitals
§ Specialty Clinics
§ Key Geographies
§ North America
§ Europe
§ Asia-Pacific and Restof the World
The Global Stem CellsMarket: Focus on Clinical Therapies, 2020–2030 (Based on Source(Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic,Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow,Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, NeuralTissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent,Pluripotent))”. report features the following companies, which weidentified to be key players in this domain:
§ Anterogen
§ Athersys
§ CHABiotech
§ Cytopeutics
§ Hope Biosciences
§ Japan RegenerativeMedicine
§ Lineage CellTherapeutics
§ Orchard Therapeutics
§ Osiris Therapeutics
§ PluristemTherapeutics
§ PromitheraBiosciences
§ Regenexx
§ Stempeutics Research
§ SCM Life Sciences
§ TICEBA
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Key Therapeutic Areas
7. Assessment of Relative Competition and GrowthOpportunities
8. Academic Grants Analysis
9. Clinical Trail Analysis
10. Stem Cell Manufacturing Market Landscape and KPIsfor Evaluating Contract
Services Partners
11. Stem Cell Therapy Developers and CMOs: OpportunityAssessment
12. Key Commercialization Strategies
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
